Related Experiment Video
Updated: Mar 26, 2026
Immunoglobulin Gene Sequence Analysis In Chronic Lymphocytic Leukemia: From Patient Material To Sequence Interpretation
Published on: November 26, 2018
Current concepts in diagnosis and treatment of chronic lymphocytic leukemia
1Department of Clinical Transplantology, Medical University of Lublin, Poland.
Insights
Chronic lymphocytic leukemia (CLL) is a common adult leukemia, particularly in the elderly. Recent advances offer new treatment options for both initial and resistant disease, improving patient outcomes.
Area of Science:
- Hematology
- Oncology
Background:
- Chronic lymphocytic leukemia (CLL) is the most common leukemia in adults in Western countries.
- CLL predominantly affects the elderly, often with comorbidities, complicating treatment decisions.
Purpose of the Study:
- To review current diagnostic principles and prognostic factors in CLL.
- To outline therapeutic strategies for first-line and refractory/resistant CLL.
- To discuss novel therapeutic molecules in clinical trials.
Main Methods:
- Review of current diagnostic and therapeutic approaches for CLL.
- Discussion of prognostic factors influencing treatment selection.
- Evaluation of established and emerging therapies, including immunochemotherapy and small molecule inhibitors.
Main Results:
- Significant progress in CLL treatment with immunochemotherapy and targeted small molecules.
- Comprehensive overview of treatment options for diverse patient groups, including those with poor performance status and high-risk disease.
- Identification of novel agents under clinical investigation.
Conclusions:
- Modern treatment paradigms for CLL have evolved significantly.
- Personalized therapeutic strategies are crucial for managing CLL in elderly patients with comorbidities.
- Ongoing research promises further advancements in CLL management.
Abstract:
Chronic lymphocytic leukemia (CLL) is the most commonly diagnosed type of leukemia in Western Europe and North America, and represents about 30% of all leukemias in adults. Chronic lymphocytic leukemia is a disease of the elderly, who are often in poorer general health and burdened with multiple comorbidities. These factors affect the decision making when choosing an appropriate method of treatment. In recent years there has been significant progress in the treatment of chronic lymphocytic leukemia, first due to the introduction of immunochemotherapy with monoclonal antibodies and latterly small molecules, like tyrosine kinase inhibitors targeting B-cell receptor signaling. This article discusses the current diagnostic principles, the most important prognostic factors and therapeutic options, available in first-line treatment and in refractory/resistant disease, including high-risk CLL, both for patients with good and those with poor performance status. It also presents important novel molecules which have been evaluated in clinical trials.
More Related Videos
11:29HPLC-based Assay to Monitor Extracellular Nucleotide/Nucleoside Metabolism in Human Chronic Lymphocytic Leukemia Cells
Published on: July 20, 2016
09:52A Chromatin Immunoprecipitation Assay to Identify Novel NFAT2 Target Genes in Chronic Lymphocytic Leukemia
Published on: December 4, 2018
Related Concept Videos
01:29Chronic Pancreatitis II: Collaborative Care
Assessment:
02:50Combination Therapies and Personalized Medicine
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...